https://www.marketwatch.com/story/cell-grown-meat-startup-ra…
=>
...German drugmaker Merck KGaAG and a top European meat processor are backing a startup producing beef from cattle cells, ramping up a race to transform the global meat industry with cell-culture technology.
The $8.8 million investment in Netherlands-based Mosa Meat by Merck’s venture investing unit and Basel, Switzerland-based Bell Food Group fuels a continuing effort to fulfill growing global demand for meat via a process that developers say requires a fraction of the resources used in traditional livestock and poultry production...
2018e, Thomson Reuters:
• P/E = 13.6
• div.yield = 2.48%
• EV / EBITDA = 8.18
• P/B = 1.51
• Net Debt / EBITDA = 2.23
=> die Aktie hat es - zuvor - ganz schön zerlegt:
aus: https://www.bellfoodgroup.com/de/investoren/aktieninformatio…